Christine T. Ong

Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous Administrations

Heather K. Sun, Christine T. Ong, Ambreen Umer et al. · Antimicrobial Agents and Chemotherapy · 2005 · 84 citations · Full text

Peak Tigecycline Concentration, Pharmacokinetic Modeling, Healthy Subjects +11

Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing <i>Escherichia coli</i> at Various Inocula

Dana Maglio, Christine T. Ong, Mary Anné Banevicius et al. · Antimicrobial Agents and Chemotherapy · 2004 · 71 citations · Full text

Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps

Christine T. Ong, Pamela R. Tessier, Chonghua Li et al. · Diagnostic Microbiology and Infectious Disease · 2006 · 68 citations

Antimicrobial Susceptibility, Health Sciences, Mexa-mexb-oprm Efflux Pumps +10

Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs)

Christine T. Ong, Chinedum P. Babalola, Charles H. Nightingale et al. · Journal of Antimicrobial Chemotherapy · 2005 · 49 citations

Comparison of probability of target attainment calculated by Monte Carlo simulation with meropenem clinical and microbiological response for the treatment of complicated skin and skin structure infections

Joseph L. Kuti, Christine T. Ong, Mathew M. S. Lo et al. · International Journal of Antimicrobial Agents · 2006 · 27 citations

Infectious Disease Modelling, Skin Structure Infections, Clinical Dermatology +8